Virtus LifeSci News

Virtus LifeSci Biotech Clinical Trls ETF -- USA Etf  

USD 30.81  0.52  1.66%

Macroaxis does not monitor all media channels or aggregates social signals for Virtus LifeSci. But even though we do not provide professional-grade financial sentiment analysis on Virtus LifeSci Biotech, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Virtus LifeSci. Check also Virtus LifeSci Hype Analysis, Virtus LifeSci Correlation and Virtus LifeSci Performance.
  
over a month ago at kldaily.com         
Virtus LifeSci Biotech Clinical Trls ETF Increases by 23.21 percent Following ...
news
KL Daily - Mar 10, 2018 More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on July 01, 2017, also Nasdaq.com with their article Value Biotech ETFs ...
  
  
over two months ago at friscofastball.com         
BioShares Biotechnology Clinical Trials Rises 0.1848 percent for Feb 16
news
Frisco Fastball - Feb 16, 2018 More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on July 01, 2017, also Nasdaq.com with their article MandA Waves Pushing ... BioShares Biotechnology Products Rises 0.76 percent for Feb 16 - Weekly Register
  
  
over two months ago at bzweekly.com         
Could Bioshares Biotechnology Clinical See a Reversal After ...
news
More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Globenewswire.com which released BioShares Biotechnology ETFs Complete Semi-Annual Rebalance and Recomposition on June 16, 2017, also Marketwatch.
  
  
over two months ago at bzweekly.com         
After Positive Net Flows, Virtus LifeSci Biotech Clinical Trls ETF Reports 40 ...
news
BZ Weekly - Feb 3, 2018 Virtus LifeSci Biotech Clinical Trls ETF is in the ETF category , is part of the fund family and currently has net assets. It was started on 110001.
  
  
over three months ago at www.nasdaq.com         
Biotech ETF Hits New 52-Week High
nasdaq News
Nasdaq - Jan 23, 2018 For investors seeking momentum, Virtus LifeSci Biotech Clinical Trials ETF BBC is probably on radar now. The fund just hit a 52-week high and is up nearly 76 percent from its 52-week low price of 18.49share. BioShares Biotechnology Products Rises 1.8756 percent for Jan 23 - Press Telegraph
  
  
over three months ago at weeklyregister.com         
BioShares Biotechnology Clinical Trials Rises 2.51 percent for Jan 17
news
More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article The Zacks ...
  
  
over three months ago at www.thelincolnianonline.com         
Virtus LifeSci Biotech Clinical Trials ETF Declares Annual ...
news
Virtus LifeSci Biotech Clinical Trials ETF announced an annual dividend on Thursday, December 21st, Wall Street Journal reports. Does Bioshares Biotechnology Clinical Have Gas After Even More ... - BZ Weekly Bioshares Biotechnology Clinical on Focus After Report of More ... - Press Telegraph
  
  
over three months ago at weeklyregister.com         
BioShares Biotechnology Clinical Trials Declines 0.94 percent for Dec 31
news
Weekly Register - Dec 31, 2017 More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article The Zacks ...
  
  
over three months ago at ledgergazette.com         
Virtus LifeSci Biotech Clinical Trials ETF Plans Annual Dividend of 0.30
news
The Ledger Gazette - Dec 22, 2017 Virtus LifeSci Biotech Clinical Trials ETF logo Virtus LifeSci Biotech Clinical Trials ETF declared an annual dividend on Thursday, December 21st, Wall Street Journal reports. Bioshares Biotechnology Clinical on Focus After Report of More ... - Frisco Fastball
  
  
over three months ago at bzweekly.com         
BioShares Biotechnology Clinical Trials Declines 1.778 percent for Dec 14
news
More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article Value Biotech ... BioShares Biotechnology Products Declines 1.04 percent for Dec 14 - Weekly Register
  
  
over three months ago at weeklyhub.com         
BioShares Biotechnology Clinical Trials Rises 1.5468 percent for Dec 8
news
WeeklyHub - Dec 8, 2017 More important recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com published article titled Best ... BioShares Biotechnology Products Rises 2.0717 percent for Dec 8 - Press Telegraph
  
  
over three months ago at weeklyregister.com         
BioShares Biotechnology Clinical Trials Declines 0.48 percent for Nov 17
news
Weekly Register - Nov 17, 2017 More notable recent Virtus LifeSci Biotech Clinical Trials ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article Best Sector ... Bioshares Biotechnology Clinical Can39t Be Less Risky. Short ... - KL Daily
  
  
over three months ago at finnewsdaily.com         
BioShares Biotechnology Products Rises 0.3 percent for Nov 1
news
... ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Products ETF on December 17, 2014, also Marketwatch.
  
  
over six months ago at weeklyregister.com         
BioShares Biotechnology Products Declines 2.5 percent for Oct 24
news
Weekly Register - Oct 24, 2017 ... Virtus LifeSci Biotech Products ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Products ETF on December 17, 2014, also Marketwatch.com with their article Virtus LifeSci Biotech Clinical Trials ...
  
  
over six months ago at weeklyhub.com         
Bioshares Biotechnology Clinical Ca not Be More Risky. Short ...
news
More notable recent Virtus LifeSci Biotech Clinical Trials ETF news were published by Benzinga.com which released Life Lessons The Hows And Whos To Play Biotech on October 06, 2017, also Globenewswire. Is Bioshares Biotechnology Clinical a Buy The Stock Reported ... - BZ Weekly
  

Latest Stories

Recently Published Macroaxis Headlines

Virtus LifeSci Performance

Performance against DOW
 Price Growth (%)  
      Timeline 

Pair Trading

Virtus LifeSci Pair Trading Analysis
Correlation analysis and pair trading evaluation for Virtus LifeSci and Davis Select Financial. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Check also Virtus LifeSci Hype Analysis, Virtus LifeSci Correlation and Virtus LifeSci Performance. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.